Short BiographyIn his current role, he uses toxicological and regulatory guidelines to provide guidance on marketed tobacco products and issues. Most recently he has lead the effort to synthesize and publish results of Cigarette Ingredient Testing Program conducted by Philip Morris USA, resulting in publication of a special issue of Inhalation Toxicology (Vol. 23, Supplement 1, June 2011) and a subsequent paper on the discriminatory power of assays used in this testing program. Previously, he has held leadership roles in genomics/proteomics, and aerosol dosimetry groups within Research, Development and Engineering.Prior to joining PM USA in 2007, he held a variety of academic positions at the University of California, Irvine. His researched focused on inhalation toxicology with an emphasis in particulate dosimetry (human and animal) and tobacco smoke particulates. Since 1981 he has also held a variety of management positions in quality assurance, regulatory affairs, and research and development for a variety of large and start-up medical device and pharmaceutical companies. Dr. Oldham received a bachelor’s degree in biology, masters of science in administration and Ph.D. in environmental toxicology from the University of California, Irvine. He has published over 70 articles in scientific peer-reveiwed journals.